LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | Barasertib | 1.11 | uM | LJP5 | 2 | D09 | 72 | hr | 765 | 1017 | 3151 | 0.3227 | 0.1496 |
Hs 578T | Barasertib | 1.11 | uM | LJP5 | 3 | D09 | 72 | hr | 765 | 1013 | 3152 | 0.3213 | 0.1473 |
Hs 578T | Barasertib | 3.33 | uM | LJP5 | 1 | D08 | 72 | hr | 765 | 902 | 3140 | 0.2872 | 0.0842 |
Hs 578T | Barasertib | 3.33 | uM | LJP5 | 2 | D08 | 72 | hr | 765 | 995 | 3151 | 0.3157 | 0.1373 |
Hs 578T | Barasertib | 3.33 | uM | LJP5 | 3 | D08 | 72 | hr | 765 | 939 | 3152 | 0.2979 | 0.1055 |
Hs 578T | Barasertib | 10 | uM | LJP5 | 1 | D07 | 72 | hr | 765 | 880 | 3140 | 0.2802 | 0.0711 |
Hs 578T | Barasertib | 10 | uM | LJP5 | 2 | D07 | 72 | hr | 765 | 864 | 3151 | 0.2741 | 0.0614 |
Hs 578T | Barasertib | 10 | uM | LJP5 | 3 | D07 | 72 | hr | 765 | 846 | 3152 | 0.2684 | 0.0505 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 1 | C18 | 72 | hr | 765 | 3336 | 3140 | 1.0623 | 1.0602 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 2 | C18 | 72 | hr | 765 | 3309 | 3151 | 1.0499 | 1.0483 |
Hs 578T | Vemurafenib | 0.04 | uM | LJP5 | 3 | C18 | 72 | hr | 765 | 3303 | 3152 | 1.0478 | 1.0462 |
Hs 578T | Vemurafenib | 0.12 | uM | LJP5 | 1 | C17 | 72 | hr | 765 | 3299 | 3140 | 1.0505 | 1.0490 |
Hs 578T | Vemurafenib | 0.12 | uM | LJP5 | 2 | C17 | 72 | hr | 765 | 3214 | 3151 | 1.0198 | 1.0193 |
Hs 578T | Vemurafenib | 0.12 | uM | LJP5 | 3 | C17 | 72 | hr | 765 | 3260 | 3152 | 1.0341 | 1.0331 |
Hs 578T | Vemurafenib | 0.37 | uM | LJP5 | 1 | C16 | 72 | hr | 765 | 3344 | 3140 | 1.0648 | 1.0626 |
Hs 578T | Vemurafenib | 0.37 | uM | LJP5 | 2 | C16 | 72 | hr | 765 | 3322 | 3151 | 1.0541 | 1.0522 |
Hs 578T | Vemurafenib | 0.37 | uM | LJP5 | 3 | C16 | 72 | hr | 765 | 3195 | 3152 | 1.0135 | 1.0132 |
Hs 578T | Vemurafenib | 1.11 | uM | LJP5 | 1 | C15 | 72 | hr | 765 | 3294 | 3140 | 1.0489 | 1.0474 |
Hs 578T | Vemurafenib | 1.11 | uM | LJP5 | 2 | C15 | 72 | hr | 765 | 3279 | 3151 | 1.0404 | 1.0392 |
Hs 578T | Vemurafenib | 1.11 | uM | LJP5 | 3 | C15 | 72 | hr | 765 | 3299 | 3152 | 1.0465 | 1.0450 |
Hs 578T | Vemurafenib | 3.33 | uM | LJP5 | 1 | C14 | 72 | hr | 765 | 3000 | 3140 | 0.9553 | 0.9556 |
Hs 578T | Vemurafenib | 3.33 | uM | LJP5 | 2 | C14 | 72 | hr | 765 | 2986 | 3151 | 0.9474 | 0.9478 |
Hs 578T | Vemurafenib | 3.33 | uM | LJP5 | 3 | C14 | 72 | hr | 765 | 3057 | 3152 | 0.9697 | 0.9701 |
Hs 578T | Vemurafenib | 10 | uM | LJP5 | 1 | C13 | 72 | hr | 765 | 1872 | 3140 | 0.5961 | 0.5515 |
Hs 578T | Vemurafenib | 10 | uM | LJP5 | 2 | C13 | 72 | hr | 765 | 1953 | 3151 | 0.6197 | 0.5823 |